Recently, we showed that certain polymorphisms of apolipoprotein-E (APO-E) synthesized after TBI in the central nervous system, including the hypothalamus–pituitary region, reduce the risk of pituitary insufficiency, and for this, one must take into account individual differences in treatment [5]. This evidence concerns the gene APOE and hypopituitarism.